Whitney Andrews and Michael Jones of PCCA discuss how strong cultures in a business lead to a stronger business overall.

Maria Carvalho, Manager of PCCA Science, explains scientific poster presentations and why they are important when it comes to peer-reviewed research of pharmacy compounding

Congratulations to Ashley Barton, CPhT, Director of Compounding Operations of Peoples Rx in Austin, Texas, which is owned by Bill Swail, RPh, for being our July Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of pharmacy compounding by providing the highest quality of service to their patients.

Amy Shank, PCCA's Director of Government Relations provides an exciting update about PCCA's 2021 ACT Legislative Conference, detailing the conversation between pharmacists and their legislators.

Culture is created by the enhanced exposure to an organization’s mission, vision and values. If potential employees can see your values and behaviors as a business, this helps set the expectations and provide a positive experience for both current and future employees.

Melissa Merrell Rhoads and Courtaney Davis discuss the factors to consider when choosing the right suppository base in pharmacy compounding.

John Preckshot explains detoxification and discusses various methods of removing or diminishing toxins in the body.

PCCA's Research and Development team is populated with hard-working, dedicated pharmacy professionals who strive each day to make a difference in pharmacy compounding. As a team, they act as a key component of PCCA's abiding desire to provide pharmacies with formulas that alleviate patient health challenges. The Research and Development Spotlight is a limited series of articles designed to highlight members of the research and development team. This article focuses on Daniel Banov and Fabiana Banov

Beau Harger discusses some of the opportunities that pharmacy compounders have to help patients struggling with seasonal health challenges.

Matt Martin of PCCA Clinical Services and Melissa Merrell Rhoads, Director of Formulation development discuss two possible alternatives to Dichloralphenazone for compounding pharmacists.